glp-1 prescriptions growth slowdown 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Driver: IQVIA's Update GLP-1 Receptor Agonist Market Size,

DOI: 10.3390/nu11020247, Fujiwara, Y., Eguchi, S., Murayama, H., et al

The body requires signals to determine which tissue to keep and which tissue to lose

Most GLP-1a weight loss and type diabetes medications require a prior authorization (PA) from the insurance provider: FDA-approved weight loss medications: Contrave, Saxenda (liraglutide), Wegovy (semaglutide) Zepbound (tirzepatide) FDA-approved Diabetes medications: Rybelsis, Victoza (liraglutide), Ozempic (semaglutide), or Mounjaro (tirzepatide) If your insurance company says that they cover FDA-approved diabetes medications, it suggests coverage for patients with type 2 diabetes

Wegovy is approved for use for weight management

& Mulvihill, E

Wing RR, Jeffery RW